IBDEI2LX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43757,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,43757,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,43757,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,43758,0)
 ;;=M34.2^^200^2217^273
 ;;^UTILITY(U,$J,358.3,43758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43758,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,43758,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,43758,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,43759,0)
 ;;=M34.81^^200^2217^275
 ;;^UTILITY(U,$J,358.3,43759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43759,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,43759,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,43759,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,43760,0)
 ;;=M34.82^^200^2217^276
 ;;^UTILITY(U,$J,358.3,43760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43760,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,43760,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,43760,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,43761,0)
 ;;=M34.83^^200^2217^277
 ;;^UTILITY(U,$J,358.3,43761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43761,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,43761,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,43761,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,43762,0)
 ;;=M34.89^^200^2217^274
 ;;^UTILITY(U,$J,358.3,43762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43762,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,43762,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,43762,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,43763,0)
 ;;=M34.9^^200^2217^278
 ;;^UTILITY(U,$J,358.3,43763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43763,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,43763,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,43763,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,43764,0)
 ;;=R21.^^200^2217^257
 ;;^UTILITY(U,$J,358.3,43764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43764,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,43764,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,43764,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,43765,0)
 ;;=R23.3^^200^2217^269
 ;;^UTILITY(U,$J,358.3,43765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43765,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,43765,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,43765,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,43766,0)
 ;;=L03.113^^200^2217^112
 ;;^UTILITY(U,$J,358.3,43766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43766,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,43766,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,43766,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,43767,0)
 ;;=L03.114^^200^2217^105
 ;;^UTILITY(U,$J,358.3,43767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43767,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,43767,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,43767,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,43768,0)
 ;;=L03.115^^200^2217^109
 ;;^UTILITY(U,$J,358.3,43768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43768,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,43768,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,43768,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,43769,0)
 ;;=L03.116^^200^2217^102
 ;;^UTILITY(U,$J,358.3,43769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43769,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,43769,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,43769,2)
 ;;=^5133645
 ;;^UTILITY(U,$J,358.3,43770,0)
 ;;=L03.123^^200^2217^27
 ;;^UTILITY(U,$J,358.3,43770,1,0)
 ;;=^358.31IA^4^2
